Last reviewed · How we verify

Bentyl — Competitive Intelligence Brief

Bentyl (dicycloverine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticholinergic. Area: Neuroscience.

marketed Anticholinergic Histamine H2 receptor Neuroscience Live · refreshed every 30 min

Target snapshot

Bentyl (dicycloverine) — Forest Labs Inc.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Bentyl TARGET dicycloverine Forest Labs Inc marketed Anticholinergic Histamine H2 receptor 1950-01-01
Axid Ar NIZATIDINE marketed Histamine-2 Receptor Antagonist [EPC] Histamine H2 receptor 1988-01-01
Zantac ranitidine GSK (originally Glaxo) marketed H2 receptor antagonist Multidrug and toxin extrusion protein 1, Acetylcholinesterase, Histamine H2 receptor 1983-06-01
Histalog BETAZOLE marketed betazole Histamine H2 receptor 1982-01-01
Tagamet CIMETIDINE marketed Histamine-2 Receptor Antagonist [EPC] Histamine H2 receptor 1977-01-01
Rosuvastatin-ranitidine Rosuvastatin-ranitidine Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec marketed Fixed-dose combination: HMG-CoA reductase inhibitor + H2-receptor antagonist HMG-CoA reductase (rosuvastatin component); Histamine H2 receptor (ranitidine component)
Drug: cimetidine Drug: cimetidine University of Maryland, Baltimore marketed H2 receptor antagonist Histamine H2 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticholinergic class)

  1. · 4 drugs in this class
  2. Pearl Therapeutics, Inc. · 3 drugs in this class
  3. Shionogi · 2 drugs in this class
  4. Ain Shams University · 1 drug in this class
  5. Astellas Pharma Inc · 1 drug in this class
  6. Boehringer Ingelheim · 1 drug in this class
  7. Covis · 1 drug in this class
  8. Forest Labs Inc · 1 drug in this class
  9. Fougera Pharms · 1 drug in this class
  10. Glaxo Grp England · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bentyl — Competitive Intelligence Brief. https://druglandscape.com/ci/dicycloverine. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing